These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Genomics and large scale phenotypic databases. Winkelmann BR Pharmacogenomics; 2001 Feb; 2(1):3-5. PubMed ID: 11258195 [TBL] [Abstract][Full Text] [Related]
26. The American Heart Association's New Institute for Precision Cardiovascular Medicine. Houser SR Circulation; 2016 Dec; 134(24):1913-1914. PubMed ID: 27881558 [No Abstract] [Full Text] [Related]
27. Something Old, Something New: Using Family History and Genetic Testing to Diagnose and Manage Athletes with Inherited Cardiovascular Disease. Thomas MJ; Battle RW Clin Sports Med; 2015 Jul; 34(3):517-37. PubMed ID: 26100426 [TBL] [Abstract][Full Text] [Related]
28. [Research projects for implementation of individualized medicine]. Lieb W; Grabe HJ; Kroemer HK Dtsch Med Wochenschr; 2013 Mar; 138(13):665-6. PubMed ID: 23512371 [No Abstract] [Full Text] [Related]
29. Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype. Ashrafian H; Watkins H J Am Coll Cardiol; 2007 Mar; 49(12):1251-64. PubMed ID: 17394955 [TBL] [Abstract][Full Text] [Related]
30. The Genetic Architecture of Kidney Disease. Pollak MR; Friedman DJ Clin J Am Soc Nephrol; 2020 Feb; 15(2):268-275. PubMed ID: 31992573 [TBL] [Abstract][Full Text] [Related]
31. [Hundreds of genetic variants associated to cardiovascular disease. Revolution within population-based research--not yet in clinical practice]. Ingelsson E Lakartidningen; 2011 Jan 12-18; 108(1-2):26-30. PubMed ID: 21365810 [No Abstract] [Full Text] [Related]
32. Linking Genes to Cardiovascular Diseases: Gene Action and Gene-Environment Interactions. Pasipoularides A J Cardiovasc Transl Res; 2015 Dec; 8(9):506-27. PubMed ID: 26545598 [TBL] [Abstract][Full Text] [Related]
33. Clinical validation of genetic markers for improved risk estimation. Kessler T; Schunkert H Eur J Prev Cardiol; 2012 Aug; 19(2 Suppl):25-32. PubMed ID: 22801067 [TBL] [Abstract][Full Text] [Related]
34. Genetic association studies in cardiovascular diseases: Do we have enough power? Auer PL; Stitziel NO Trends Cardiovasc Med; 2017 Aug; 27(6):397-404. PubMed ID: 28456354 [TBL] [Abstract][Full Text] [Related]
35. Genetics, genomics, proteomics: what is a cardiologist to do? Califf RM Am Heart J; 2000 Oct; 140(4):S48-50. PubMed ID: 11011324 [No Abstract] [Full Text] [Related]
37. Coarctation of the aorta: are genes relevant? Francis CM J Cardiovasc Surg (Torino); 2016 Aug; 57(4):546-56. PubMed ID: 27243623 [TBL] [Abstract][Full Text] [Related]
38. Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine. Sookoian S; Pirola CJ World J Gastroenterol; 2015 Jan; 21(3):711-25. PubMed ID: 25624707 [TBL] [Abstract][Full Text] [Related]
39. Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine. Ouzounian M; Lee DS; Gramolini AO; Emili A; Fukuoka M; Liu PP Can J Cardiol; 2007 Aug; 23 Suppl A(Suppl A):28A-33A. PubMed ID: 17668085 [TBL] [Abstract][Full Text] [Related]